Search results
Results from the WOW.Com Content Network
Prior to studying medicine, Robert Malone studied computer science at Santa Barbara City College for two years, acting as a teaching assistant in 1981. [2] [8] He received his BS in biochemistry from the University of California, Davis in 1984, his MS in biology from the University of California, San Diego in 1988, and his MD from Northwestern University Feinberg School of Medicine in 1991.
Initially, MacLachlan and Tekmira turned away from the collaboration. Karikó wanted to team up with Ian MacLachlan because he was the leader of a team that helped advance mRNA technology. Karikó was working on establishing the formulated lipid nanoparticle delivery system that encapsulates mRNA in a dense particle through a mixing process ...
In a 2011 article published by Time, [4] Ayyadurai claimed to have invented email, as a teenager; in August 1982, he registered the copyright on an email application he had written, asserting in his copyright filing, "I, personnally, feel EMAIL is as sophisticated as any electronic mail system on the market today." Historians strongly dispute ...
When the SARS-CoV-2 virus emerged in China in 2019, BioNTech had already used mRNA technology to design a vaccine against the Zika virus, which had infected hundreds of thousands of pregnant women ...
Two pioneering scientists who created the technology behind life-saving Covid-19 vaccines have won the Nobel Prize in medicine or physiology.
The University of Pennsylvania has been criticised for celebrating the Nobel prize win of Drew Weissman and Katalin Karikó for their work on vaccines as it once allegedly encouraged the latter ...
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Hoerr did experimental research on the stabilization of messenger ribonucleic acid (mRNA). In 1999, he received his PhD from Günther Jung, Institute of Organic Chemistry, in cooperation with Hans-Georg Rammensee, Institute of Immunology and Cell Biology (both: University of Tübingen) on the topic of RNA vaccines for the induction of specific cytotoxic T lymphocytes (CTL) and antibodies.